Afon Technology logo with no background

Meet The Clinical Advisors

Supporting the research and production of the revolutionary Glucowear™ are our clinical advisors. Highly respected experts in their field, their time and work with Afon Technology is extremely valuable.

Professor-Melanie-Davies-Afon Technology


Professor Melanie Davies CBE, MB ChB, MD, FRCP, FRCGP, FMedSci is Professor of Diabetes Medicine at the University of Leicester and an Honorary Consultant Diabetologist at the University Hospitals of Leicester NHS Trust. She is the Co-Director of the Leicester Diabetes Centre, University Hospitals of Leicester NHS Trust.

In 2016 Professor Melanie Davies was awarded the CBE (Commander of the Most Excellent Order of the British Empire) in the New Year’s Honour’s List for services to diabetes research. Her research interests include the causes, screening, prevention, self-management and treatment of type 2 diabetes mellitus. During her career so far she has published over 800 original articles and has had over £86M of grant funding awarded.

She is a National Institute for Health Research Senior Investigator Emeritus and Director of the NIHR Leicester Biomedical Research Centre and co-chair of EASD/ADA’s Consensus Report on T2DM Management. Professor Davies provides clinical advisory services to Afon Technology. 

David C. Klonoff, MD


Professor Dr. David C. Klonoff MD, is an endocrinologist specialising in diabetes technology. He is a clinical professor of medicine at UC San Francisco and medical director of the Diabetes Research Institute of Mills-Peninsula Medical Center (Sutter Health) in San Mateo, California.

Dr Klonoff received the American Diabetes Association’s 2019 Outstanding Physician Clinician Award. He received an FDA Director’s Special Citation Award in 2010 for outstanding contributions related to diabetes technology. Dr Klonoff received the IEEE Standards Association Conformity Assessment Award in 2022. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE), the American College of Physicians, and the Royal College of Physicians of Edinburgh. Dr Klonoff has been invited to speak to the US Congressional Diabetes Caucus, participate in the White House Health and Cybersecurity Roundtable, and speak at the European Parliament.

He is the founding editor-in-chief of Journal of Diabetes Science and Technology and he also founded Diabetes Technology & Therapeutics. He founded the Diabetes Technology Meeting and the Hospital Diabetes Meeting. He is senior editor of the world’s first three books about diabetes digital health and published the first article to show that, in COVID-19, correcting the hyperglycaemia of diabetes enhances recovery.

Prof. Dr. Lutz Heinemann Afon Technology


Professor Heinemann sits on the Scientific Advisory Boards of several pharmaceutical and diagnostics companies and holds memberships of both national and international diabetes associations. His background of scientific research has been focused on insulin pharmacology and diabetes technology.

After qualifying as an Engineer and Biologist, Professor Heinemann became an Assistant Professor in the Neurophysiology Department at Düsseldorf University and then spent over a decade at the Clinic for Nutrition and Metabolism in the Centre for Internal Medicine and Neurology. In 1999, Professor Heinemann founded the Profil Institut für Stoffwechselforschung in Neuss, Germany and was CEO until 2009. Professor Heinemann has won two prestigious awards from the Diabetes Technology Society. In 2007 he was recognised for ‘Leadership in Diabetes Technology’ and in 2012 won the ‘Artificial Pancreas Research Award’.

Since 2011 Professor Heinemann has been the Managing Editor of the Journal of Diabetes Science and Technology and continues to play an active part as member of the Program Committee of the Diabetes Technology Meeting and Member of the Program Committee of the ATTD Meeting. Professor Heinemann provides clinical advisory services to Afon Technology. 

Sign up to our newsletter